We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$713B
AUM Growth
+$53.3B
Cap. Flow
+$8.84B
Cap. Flow %
1.24%
Top 10 Hldgs %
20.41%
Holding
5,090
New
62
Increased
3,440
Reduced
905
Closed
188

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$784M
2
AAPL icon
Apple
AAPL
+$427M
3
DHR icon
Danaher
DHR
+$417M
4
PLD icon
Prologis
PLD
+$405M
5
AMZN icon
Amazon
AMZN
+$383M

Sector Composition

Rank Sector Weight
1 Technology 22.94%
2 Healthcare 15.43%
3 Financials 13.92%
4 Consumer Discretionary 9.78%
5 Industrials 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRG
5076
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
-540,766
Closed -$14.5M
AMPE
5077
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-5,474
Closed -$99K
DRE
5078
DELISTED
Duke Realty Corp.
DRE
-7,127,153
Closed -$343M
CHNG
5079
DELISTED
Change Healthcare Inc. Common Stock
CHNG
-3,528,375
Closed -$97M
ABTX
5080
DELISTED
Allegiance Bancshares
ABTX
-340,119
Closed -$14.2M
CTXS
5081
DELISTED
Citrix Systems Inc
CTXS
-2,302,805
Closed -$239M
BXRX
5082
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
-1,639
Closed -$16K
TRQ
5083
DELISTED
Turquoise Hill Resources Ltd
TRQ
-27,995
Closed -$828K
NLSN
5084
DELISTED
Nielsen Holdings plc
NLSN
-7,126,146
Closed -$197M
FBC
5085
DELISTED
Flagstar Bancorp, Inc. New
FBC
-933,315
Closed -$31.2M
EVK
5086
DELISTED
Ever-Glory International Group, Inc.
EVK
-13,112
Closed -$11K
PEI
5087
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
-33,133
Closed -$96K
SVA
5088
DELISTED
Sinovac Biotech, Ltd
SVA
-27,717
Closed -$179K
RNWK
5089
DELISTED
RealNetworks Inc
RNWK
-262,107
Closed -$181K
BHVN
5090
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-1,097,362
Closed -$166M

Similar funds

Geode Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Geode Capital Management held 5,090 positions worth $713B, up 8.1% from $659B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. Geode Capital Management opened 62 new positions and exited 188, leaving the 5,090-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q4 2022 buy was Ferguson: 1,854,192 shares worth $235M.
  • Geode Capital Management added most to Microsoft in Q4 2022, an estimated $784M increase.
  • Geode Capital Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $491M.
  • Geode Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $587M.
  • Geode Capital Management's ten largest holdings make up 20% of its $713B portfolio in Q4 2022.
  • Geode Capital Management opened 62 new positions and closed 188 in Q4 2022.
  • Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $713B.

Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.